4//SEC Filing
CorMedix Inc. 4
Accession 0001144204-15-066456
$CRMDCIK 0001410098operating
Filed
Nov 16, 7:00 PM ET
Accepted
Nov 17, 4:28 PM ET
Size
17.3 KB
Accession
0001144204-15-066456
Insider Transaction Report
Form 4
CorMedix Inc.CRMD
Duffy Matthew
Director
Transactions
- Award
Phantom Stock
2015-11-13+594→ 594 total→ Common Stock (594 underlying)
Holdings
- 30,000
Stock Option (right to buy)
Exercise: $2.02Exp: 2024-01-09→ Common Stock, $0.001 par value per share (30,000 underlying) - 50,000
Stock Option (right to buy)
Exercise: $5.62Exp: 2025-03-01→ Common Stock, $0.001 par value per share (50,000 underlying) - 53,223
Common Stock, $0.001 par value per share
- 25,000
Warrant (right to purchase Common Stock)
Exercise: $0.40From: 2012-11-13Exp: 2017-11-13→ Common Stock, $0.001 par value per share (25,000 underlying) - 5,000
Stock Option (right to buy)
Exercise: $0.29Exp: 2022-01-06→ Common Stock, $0.001 par value per share (5,000 underlying) - 15,000
Stock Option (right to buy)
Exercise: $0.28Exp: 2021-11-21→ Common Stock, $0.001 par value per share (15,000 underlying) - 125,000
Stock Option (right to buy)
Exercise: $0.68Exp: 2022-12-05→ Common Stock, $0.001 par value per share (125,000 underlying) - 150,000
Stock Option (right to buy)
Exercise: $2.02Exp: 2024-01-09→ Common Stock, $0.001 par value per share (150,000 underlying) - 100,000
Stock Option (right to buy)
Exercise: $0.90Exp: 2023-03-20→ Common Stock, $0.001 par value per share (100,000 underlying)
Footnotes (8)
- [F1]These options vested 100% on January 10, 2014.
- [F2]These options vest in full on the first anniversary of the date of grant.
- [F3]These options vest quarterly over two years.
- [F4]These options vest as follows: (a) fifty percent (50%) on the date of issuance of the CE Mark certification for Neutrolin in Europe, which occurred on July 5, 2013, and (b) fifty percent (50%) on December 31, 2013.
- [F5]On November 13, 2012, the reporting person acquired in a private placement $10,000 of (a) 9% Senior Convertible Notes, convertible into shares of the Company's common stock at a conversion price of $0.35 per share, and (b) a five-year redeemable warrant to purchase common stock at an exercise price of $0.40 per share.
- [F6]The options vest ratably, one-third of which will vest on each of the grant date, the first anniversary and the second anniversary thereof.
- [F7]Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock on the tenth business day of January of the year following the reporting person's termination of service as a directo
- [F8]These shares were credited automatically to the reporting person's account pursuant to the reporting person's election to defer the receipt of cash compensation of directors fees.
Documents
Issuer
CorMedix Inc.
CIK 0001410098
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001410098
Filing Metadata
- Form type
- 4
- Filed
- Nov 16, 7:00 PM ET
- Accepted
- Nov 17, 4:28 PM ET
- Size
- 17.3 KB